Larimar Therapeutics LRMR SEC Filings

NASDAQ LRMR
$2.46 +0.02 (+1.02%)
As of: Oct 21, 2026 · 1:10 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Larimar Therapeutics, Inc. (LRMR) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
14Insider Transaction0001193125-26-410719Oct 1, 2026 12:27 AM
23Insider Transaction0001193125-26-410715Oct 1, 2026 12:26 AM
38-KCurrent Report0001193125-26-407331Sep 29, 2026 4:06 PM
410-QQuarterly & Annual Report0001193125-26-331529Aug 4, 2026 7:12 AM
58-KCurrent Report0001193125-26-331516Aug 4, 2026 7:02 AM
64Insider Transaction0001193125-26-298523Jul 8, 2026 8:05 PM
78-KCurrent Report0001193125-26-286780Jun 29, 2026 10:33 AM
84Insider Transaction0001193805-26-000669May 20, 2026 12:02 AM
94Insider Transaction0001193125-26-232933May 20, 2026 10:03 PM
104Insider Transaction0001193125-26-232705May 20, 2026 8:30 PM
114Insider Transaction0001193125-26-232667May 20, 2026 8:28 PM
124Insider Transaction0001193125-26-232657May 20, 2026 8:24 PM
134Insider Transaction0001193125-26-232644May 20, 2026 8:21 PM
148-KCurrent Report0001193125-26-230852May 19, 2026 8:27 PM
15SCHEDULE 13G/AOthers0001140361-26-021322May 14, 2026 4:23 PM-
1610-QQuarterly & Annual Report0001193125-26-224087May 14, 2026 4:18 PM-
178-KCurrent Report0001193125-26-222746May 14, 2026 7:02 AM-
18SCHEDULE 13GBeneficial Ownership Report0001104659-26-053218Apr 30, 2026 6:17 PM
19SCHEDULE 13GBeneficial Ownership Report0001104659-26-053218Apr 30, 2026 6:17 PM
20SCHEDULE 13GBeneficial Ownership Report0001104659-26-053218Apr 30, 2026 6:17 PM
21ARSOthers0001193125-26-163954Apr 20, 2026 8:08 PM
22DEF 14AOthers0001193125-26-163942Apr 20, 2026 8:06 PM
23PRE 14AOthers0001193125-26-151258Apr 10, 2026 8:09 PM
24S-8Prospectus0001193125-26-116159Mar 19, 2026 9:03 PM
2510-KQuarterly & Annual Report0001193125-26-115878Mar 19, 2026 7:41 PM
268-KCurrent Report0001193125-26-115119Mar 19, 2026 11:04 AM
278-KCurrent Report0001193125-26-098493Mar 9, 2026 8:08 PM
28SCHEDULE 13DBeneficial Ownership Report0001193805-26-000206Mar 2, 2026 12:46 AM
294Insider Transaction0001193805-26-000205Mar 2, 2026 12:46 AM
304Insider Transaction0001193805-26-000205Mar 2, 2026 12:46 AM
314Insider Transaction0001193805-26-000205Mar 2, 2026 12:46 AM
324Insider Transaction0001193125-26-085515Mar 2, 2026 9:30 PM
334Insider Transaction0001193125-26-085515Mar 2, 2026 9:30 PM
344Insider Transaction0001193125-26-085515Mar 2, 2026 9:30 PM
354Insider Transaction0001193125-26-085514Mar 2, 2026 9:30 PM
364Insider Transaction0001193125-26-085514Mar 2, 2026 9:30 PM
374Insider Transaction0001193125-26-085514Mar 2, 2026 9:30 PM
384Insider Transaction0001193125-26-085510Mar 2, 2026 9:30 PM
394Insider Transaction0001193125-26-085510Mar 2, 2026 9:30 PM
404Insider Transaction0001193125-26-085510Mar 2, 2026 9:30 PM
418-KCurrent Report0001193125-26-077646Feb 27, 2026 10:48 PM
42424B5Prospectus0001193125-26-076775Feb 26, 2026 9:20 PM
43424B5Prospectus0001193125-26-071493Feb 25, 2026 9:05 PM
448-KCurrent Report0001193125-26-065186Feb 24, 2026 12:02 PM
45SCHEDULE 13GBeneficial Ownership Report0001346824-26-000047Feb 17, 2026 9:33 PM
46SCHEDULE 13GBeneficial Ownership Report0001140361-26-005033Feb 12, 2026 9:36 PM
474Insider Transaction0001193125-26-024833Jan 27, 2026 10:04 PM
484Insider Transaction0001193125-26-024833Jan 27, 2026 10:04 PM
494Insider Transaction0001193125-26-024833Jan 27, 2026 10:04 PM
504Insider Transaction0001193125-26-024832Jan 27, 2026 10:04 PM
...

Larimar Therapeutics, Inc. SEC Filings API

Pull Larimar Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=LRMR&formtype=10-K,10-Q&api_key=YOUR_API_KEY